Status:
COMPLETED
Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
36-72 years
Phase:
NA
Brief Summary
Families seeking evaluation for autism spectrum disorder (ASD) often face barriers such as low availability of specialists, lengthy waitlists, and long distances to tertiary care diagnostic centers. T...
Detailed Description
Innovative telemedicine practices could address many existing traditional barriers to ASD identification. Telemedicine has the potential to put linguistically and culturally competent clinical expert ...
Eligibility Criteria
Inclusion
- Initial deployment (n = 30):
- English/Spanish Speaking families
- Children 36-72 months of age
- access to a device capable of supporting Zoom
- already has participated in a diagnostic evaluation
- Novel sample (n = 120):
- Inclusion
- English/Spanish Speaking families
- Children 36-72 months of age
- access to a device capable of supporting Zoom
- has not participated in a diagnostic evaluation
Exclusion
- Initial deployment (n = 30):
- severe sensorimotor impairments
- Novel sample (n = 120):
- \- severe sensorimotor impairments
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 14 2024
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT05373173
Start Date
June 1 2022
End Date
August 14 2024
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212